ProQR Therapeutics NV Live Stock Price Today, Share Analysis and Chart

Name: ProQR Therapeutics N.V: Is Infosys Ltd. worth buying?
Item: ProQR Therapeutics N.V
Rating: 1.40316675
Author: Trendlyne DVM scores

about

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The onl...

1.73 -0.03 (-1.70%)

44.19% Fall from 52W High

549.4K

XNAS Volume

XNAS 10 Jul, 2026 5:30 PM (EDT)

Not Eligible

Expensive Valuation

11.2 / 100

Technically Neutral

45.0 / 100

1Yr Price target upside is 377%

8 analysts

ProQR Therapeutics NV Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..